Sana Biotechnology Inc (SANA)
9.00
-0.08
(-0.88%)
USD |
NASDAQ |
Apr 30, 16:00
9.00
0.00 (0.00%)
After-Hours: 20:00
Sana Biotechnology Accounts Payable (Quarterly): 4.108M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 4.108M |
| September 30, 2023 | 9.928M |
| June 30, 2023 | 3.089M |
| March 31, 2023 | 2.334M |
| December 31, 2022 | 2.857M |
| September 30, 2022 | 3.993M |
| June 30, 2022 | 3.079M |
| March 31, 2022 | 4.765M |
| Date | Value |
|---|---|
| December 31, 2021 | 2.219M |
| September 30, 2021 | 3.947M |
| June 30, 2021 | 3.704M |
| March 31, 2021 | 4.258M |
| December 31, 2020 | 2.253M |
| September 30, 2020 | 3.889M |
| December 31, 2019 | 0.00 |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
Dec 2019
9.928M
Maximum
Sep 2023
3.628M
Average
3.704M
Median
Jun 2021
Accounts Payable (Quarterly) Benchmarks
| Rocket Pharmaceuticals Inc | -- |
| Solid Biosciences Inc | 2.032M |
| Dyne Therapeutics Inc | 22.94M |
| Taysha Gene Therapies Inc | 6.366M |
| Tenaya Therapeutics Inc | 5.63M |